GSK PLC REGISTERED SHARES LS-,3125
Technische Signale
| Signale Details | |
|---|---|
| WKN / ISIN | - / GB00BN7SWP63 |
| Börse | Hannover |
| Schluss | 16,80 |
| Spekulatives Signal |  28.10.24 |
| MACD | 29.10.24 |
| Momentum |  05.08.24 |
| Bollinger Bands | 25.09.24 |
| TBI | 14.08.24 |
| Schnitt GD 90 | 09.08.24 |
Analystenbewertung
| Bewertungstrend | aktuell | Vorwoche | Vormonat |
|---|---|---|---|
| Bewertung | 2,15 | 2,19 | 2,23 |
| Anzahl der Analysten | 20 | 21 | 22 |
| Kaufen | 10 | 10 | 10 |
| Übergewichten | 1 | 1 | 1 |
| Halten | 6 | 7 | 8 |
| Untergewichten | 2 | 2 | 2 |
| Verkaufen | 1 | 1 | 1 |
| Aktueller Durchschnitt von insgesamt 20 Analysten: 2,15 | |||
| Planzahlen (in EUR) | 2023 | 2024(e) | 2025(e) |
|---|---|---|---|
| Umsatz | 30,33 Mrd. | 31,63 Mrd. | 33,35 Mrd. |
| EBIT | 7,98 Mio. | 9,23 Mrd. | 10,07 Mrd. |
| EBITDA | 10,70 Mio. | 10,68 Mrd. | 11,67 Mrd. |
| Nettoverschuldung** | 16,00 Mrd. | 12,00 Mrd. | 8,60 Mrd. |
Umsatz |
EBIT |
EBITDA |
Nettoverschuldung** |
| Dividende | 2023 | 2024(e) | 2025(e) |
|---|---|---|---|
| Dividende / Aktie | 0,69 EUR | 0,60 GBP | 0,63 GBP |
| Dividendenrendite | 4,07% | 4,26% | 4,41% |
Dividende / Aktie (in GBP) |
Dividendenrendite (in %) |
||
| Analystenhäuser |
|---|
| AlphaValue,Argus Research Company,Baader Helvea Equity Research,Bank Vontobel AG,Baptista Research,Barclays,BBVA Corporate and Investment Bank,Beaufort Securities Limited,Berenberg,BNP Paribas Exane,BofA Global Research,Bryan Garnier & Co,CA Cheuvreux,Cantor Fitzgerald Europe,Cavendish Historical (Cenkos Securities),CFRA Equity Research,Charles Stanley & Co. Ltd.,Citigroup Inc,Collins Stewart plc,Credit Suisse,Day By Day,Deutsche Bank,Dz Bank Ag,Edison Investment Research,Equisights,Erste Group Bank AG,Evolution Securities,First Global Stockbroking (P) Ltd.,Goldman Sachs,Goodbody Stockbrokers,Guggenheim Securities, LLC,Hamburger Sparkasse AG,Helvea SA,HSBC,Independent International Investment Research,Investec Bank plc (UK),J.P. Morgan,Jefferies LLC,Kepler Capital Markets,Kepler Cheuvreux,Leerink Partners LLC,MF Global UK Limited,Mirabaud Securities Limited,Morgan Stanley,Morningstar Inc.,Natixis S.A.,New Street Research LLP,Nomura Securities Co. Ltd.,NWM Strategy,ODDO BHF Corporate & Markets,Oriel Securities Ltd.,Panmure Liberum,Panmure Liberum Historic (Panmure Liberum).,Piper Sandler Companies,Raymond James Euro Equities,Redburn Atlantic,Sanford C. Bernstein & Co., LLC,Seymour Pierce Limited,Shore Capital Group Ltd,Societe Generale Cross Asset Research,Stifel Europe,Stifel, Equities Research,TD Cowen,Truist Securities,UBS Investment Bank,WestLB AG,Wolfe Research, LLC.,Zephirin Group, Inc. |
| Hinweis |
|---|
|
Selected Data supplied by Standard & Poors
* Unabhängige Schätzung (Gewinnwachstum (in %)) ** Nettobargeldbestand bei negativen Schätzungen |